Ilaria Amodeo

About

Dr. Ilaria Amodeo is a pioneering researcher at the intersection of neonatal intensive care and pharmaceutical technology, with a primary focus on medication safety and precision dosing for the most vulnerable patients. Her groundbreaking work addresses the critical challenges of medication compounding in the Neonatal Intensive Care Unit (NICU), where premature infants are particularly susceptible to medication errors. In her highly cited 2019 study, "Robotic Therapy: Cost, Accuracy, and Times. New Challenges in the Neonatal Intensive Care Unit," Dr. Amodeo demonstrated how robotic compounding systems can significantly reduce error rates while improving cost-efficiency and preparation times. With over 11 citations, this work has established her as a leading voice in neonatal pharmaceutical safety. Her research has profound implications for clinical practice, offering evidence-based solutions to reduce iatrogenic harm in fragile newborns. Dr. Amodeo's contributions are particularly notable for bridging the gap between engineering innovation and bedside care, making her a key figure in the emerging field of automated neonatal pharmacy. Her work continues to shape protocols in NICUs worldwide, ensuring that the smallest patients receive the safest possible medication therapy.

Research Focus

Key Achievements

Top Papers

1. 1
   Robotic Therapy: Cost, Accuracy, and Times. New Challenges in the Neonatal Intensive Care Unit

   11 citations · 2019

Key Collaborators

Contact & Links